Psoriasis. Psoriasis
Conditions
Interventions
Intervention 1: Intervention group: At the beginning of the study, they will receive 80 mg of adalimumab. The next dose will be one week later (40 mg) and then every two weeks (40 mg) (the total durat
Sponsors
Tabriz University of Medical Sciences
Eligibility
Sex/Gender
All
Age
18 Years to No maximum
Inclusion criteria
Inclusion criteria: Confirmed pseuriasis Accepted Patients without responce to previous treatments Don’t use of other drugs and herbal supplments Resistance to atleast one systemic treatment
Exclusion criteria
Exclusion criteria: Allergy to Adalimumab Having active inflammation such as tuberculosis, malignancies and etc Neurological disorders Hematological disorders Moderate to severe heart failure Pregnant and breast feeding woman Mental retared patients
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Disease severity. Timepoint: At the beginning of the study, 1, 2, 3 and 4 months after receiving the intervention. Method of measurement: Psoriasis Area Severity Index Score.;Quality of life. Timepoint: Initiation of the study, 4 months after receiving the intervention. Method of measurement: Dermatologic Quality of Life Index. | — |
Countries
Iran (Islamic Republic of)
Contacts
Public ContactMehdi Amirnia
Tabriz University of Medical Sciences
Outcome results
None listed